Association of interleukin 18, interleukin 2, and tumor necrosis factor polymorphisms with subacute sclerosing panencephalitis

DNA and Cell Biology

Volumn 32, Issue 6, 2013, Pages 336-340

  Piskin, Ibrahim Etem ^a   Karakas Celik, Sevim ^a   Calik, Mustafa ^b   Abuhandan, Mahmut ^b   Kolsal, Ebru ^c   Genc, Gunes Cakmak ^a   Iscan, Akin ^d  

^a ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

^b HARRAN UNIVERSITY   (Turkey)

^c Education Hospital   (Turkey)

^d BEZMIALEM VAKIF UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 18; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN POLYMORPHISM; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; SUBACUTE SCLEROSING PANENCEPHALITIS;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INTERLEUKIN-18; INTERLEUKIN-2; MALE; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; SUBACUTE SCLEROSING PANENCEPHALITIS; TUMOR NECROSIS FACTOR-ALPHA;

MEASLES VIRUS;

EID: 84878447497     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2013.1997     Document Type: Article

References (24)

1. Abraham, L. J., and Kroeger, K. M. (1999). Impact of the-308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukoc Biol 66, 562-566.
2. Anlar, B., Söylemezog? lu, F., Aysun, S, Kö se, G., Belen, D., and Yalaz, K. (2001). Tissue inflammatory response in subacute sclerosing panencephalitis (SSPE). J Child Neurol 16, 895-900.
3. Aydin, O. F., Ichiyama, T., and Anlar, B. (2010). Serum and cerebrospinal fluid cytokine concentrations in subacute sclerosing panencephalitis. Brain Dev 32, 463-466.
4. Biet, F., Locht, C., and Kremer, L. (2002). Immunoregulatory functions of interleukin 18 and its role in defense against bacterial pathogens. J Mol Med 80, 147-162.
5. Bouzgarrou, N., Hassen, E., Schvoerer, E., Stoll-Keller, F., Bahri, O., Gabbouj, S., Cheikh, I., Maamouri, N., Mammi, N., et al. (2008). Association of interleukin-18 polymorphisms and plasma level with the outcome of chronic HCV infection. J Med Virol 80, 607-614.
6. Elgert, K. D. (2009). Cytokines. In: Immunology: Understanding the Immune System, 2nd edition. K. D. Elgert, ed. (Wiley, New Jersey), pp. 285-320.
7. Gark, R. K. (2008). Subacute sclerosing panencephalitis. J Neurol 255, 1861-1871.
8. Gascon, G. (1996). Subacute sclerosing panencephalitis. Semin Pediatr Neurol 13, 260-269.
9. Giedraitis, V., He, B., Huang, W. X., and Hillert, J. (2001). Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol 112, 146-152.
10. Hara, T., Yamashita, S., Aiba, H., Nihei, K., Koide, N., Good, R. A., et al. (2000). Measles virus-specific T helper 1/T helper 2-cytokine production in subacute sclerosing panencephalitis. J Neurovirol 6, 121-126.
11. Hirankarn, N., Manonom, C., Tangkijvanich, P., and Poovorawan, Y. (2007). Association of interleukin-18 gene polymorphism (-607A/A genotype) with susceptibility to chronic hepatitis B virus infection. Tissue Antigens 70, 160-163.
12. Inoue, T., Kira, R., Nakao, F., Ihara, K., Bassuny, W. M., Kusuhara, K., et al. (2002). Contribution of the interleukin 4 gene to susceptibility to subacute sclerosing panencephalitis. Arch Neurol 59, 822-827.
13. Nagano, I., Nakamura, S., Yoshioka, M., Onodera, J., Kogure, K., and Itoyama, Y. (1994). Expression of cytokines in brain lesions in subacute sclerosing panencephalitis. Neurology 44, 710-715.
14. Okamura, H., Tsutsi, H., Komatsu, T., Yutsudo, M., Hakura, A., Tanimoto, T., Torigoe, K., Okura, T., Nukada, Y., Hattori, K., et al. (1995). Cloning of a new cytokine that induces IFNgamma production by T cells. Nature 378, 88-91.
15. Patterson, C. E., Lawrence, D. M., Echols, L. A., and Rall, G. F. (2002). Immune-mediated protection from measles virusinduced central nervous system disease is noncytolytic and gamma interferon dependent. J Virol 76, 4497-506.
16. Pawlik, A., Domanski, L., Rozanski, J., Florczak, M., Wrzesniewska, J., Dutkiewicz, G., Dabrowska-Zamojcin, E., and Gawronska-Szklarz, B. (2005). The cytokine gene polymorphisms in patients with chronic kidney graft rejection. Transpl Immunol 14, 49-52.
17. Pujhari, S. K., Ratho, R. K., Prabhakar, S., Mishra, B., and Modi, M. (2012). TNF-a promoter polymorphism: a factor contributing to the different immunological and clinical phenotypes in Japanese encephalitis. BMC Infect Dis 12, 23.
18. Schaulies, J. S., and Reuter, D. (2010). Measles virus infection of CNS: human disease, animal models, and approaches to therapy. Med Microbiol Immunol 199, 261-271.
19. Strengell, M., Matikainen, S., Siren, J., Lehtonen, A., Foster, D., Julkunen, I., and Sareneva, T. (2003). IL-21 in synergy with IL-15 or IL-18 enhances IFN-gamma production in human NK and T cells. J Immunol 170, 5464-5469.
20. Stubblefield, Park, S. R., Widness, M., Levine, A. D., and Patterson, C. E. (2011). T cell-, interleukin-12-, and gamma interferondriven viral clearance in measles virus-infected brain tissue. J Virol 85, 3664-3676.
21. Torisu, H., Kusuhara, K., Kira, R., Bassuny, W. M., Sakai, Y., Sanefuji, M., et al. (2004). Functional MxA promoter polymorphism associated with subacute sclerosing panencephalitis. Neurology 62, 457-460.
22. Tuxhom, I. E. B. (2004). Familial subacute sclerosing panencephalitis in two siblings. Pediatr Neurol 31, 291-294.
23. Yentur, S. P., Gurses, C., Demirbilek, V., Yilmaz, G., Onal, A. E., Yapici, Z., et al. (2005). Alterations in cell-mediated immune response in subacute sclerosing panencephalitis. J Neuroimmunol 170, 179-185.
24. Yilmaz, V., Demirbilek, V., Gurses, C., Yentur, S. P., Uysal, S., Yap?c?, Z., et al. (2007). Interleukin (IL)-12, IL-2, interferon-g gene polymorphisms in subacute sclerosing panencephalitis patients. J Neurovirol 13, 410-415.